Abstract
Hepatitis B virus (HBV) reactivation with hepatic decompensation leading to acute on chronic liver failure is not uncommon. It is associated with high mortality of up to 30-70%. Prognostic factors for mortality include high bilirubin level, more prolonged prothrombin time, low platelet count and presence of pre-existing cirrhosis. Several studies addressing the efficacy of different anti-viral therapies, namely lamivudine, entecavir and tenofovir, have been performed. Although the results were not highly consistent, it appeared that use of anti-viral agents was associated with decreasing chance of mortality, subsequent HBV reactivation, disease progression, and with excellent viral suppression. The beneficial effects were most prominently observed in patients with MELD score 20-30. However, even with anti-viral therapy, patients may still have irreversible liver decompensation requiring liver transplantation if other adverse parameters. including pre-existing cirrhosis, bilirubin >20 mg/dL (340 µmol/L), prothrombin time <40%, platelet count <120 × 10(9)/L. were present. Mortality rate in patients with MELD score >30 was >92% even with prompt anti-viral treatment. Liver transplantation should be considered urgently.
References
Mar 1, 1991·Journal of Gastroenterology and Hepatology·Y Takahashi, M Shimizu
Oct 1, 1988·Journal of Hepatology·C VickersE Elias
Oct 31, 2001·Alimentary Pharmacology & Therapeutics·S W TsangJ J Sung
Nov 15, 2002·Journal of Viral Hepatitis·H L-Y ChanJ J-Y Sung
Feb 15, 2003·Journal of Hepatology·Rong-Nan ChienYun-Fan Liaw
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Man-Fung YuenChing-Lung Lai
Nov 27, 2004·Intervirology·Akihito TsubotaHiromitsu Kumada
Mar 3, 2005·Journal of Gastroenterology and Hepatology·Akihito TsubotaHiromitsu Kumada
Aug 12, 2009·Hepatology International·Shiv Kumar SarinMan-Fung Yuen
Dec 9, 2009·Journal of Gastroenterology and Hepatology·Li-Jie SunShu-Chen Li
Jun 1, 2010·Digestive Diseases and Sciences·Yao-Li CuiPing Feng
Oct 30, 2010·Journal of Hepatology·Vincent Wai-Sun WongHenry Lik-Yuen Chan
Feb 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hitendra GargAshish Kumar
Oct 18, 2011·Clinical and Experimental Medicine·Tianyan ChenYingren Zhao
Nov 22, 2011·Journal of Gastroenterology and Hepatology·Wai-Kay SetoMan-Fung Yuen
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Ankur JindalShiv K Sarin
Apr 6, 2013·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Jing LaiWei-Min Ke
Mar 4, 2014·Journal of Hepatology·Chien-Hung ChenChuan-Mo Lee
May 2, 2014·World Journal of Gastroenterology : WJG·Yang ZhangJian-Xing Luo
Oct 1, 2012·Hepatology International·Ke MaQin Ning
Citations
May 6, 2016·Gastroenterology Research and Practice·Jiao YangQi Liu
Oct 12, 2016·PloS One·Chuoji HuangYuanjia Hu
Sep 17, 2015·Diseases·Tatsuo KandaOsamu Yokosuka
Jul 5, 2018·BMC Infectious Diseases·Lubiao ChenYuehua Huang
Dec 31, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Minggang WangHanmin Li